|
Nov 15
|
Eli Lilly to invest 2 billion euros to build first German production plant -source
|
|
Nov 15
|
Lilly plans single-digit billion dollar new German plant - sources
|
|
Nov 15
|
Companies Tried to Spend Less on Cloud. Then AI Showed Up.
|
|
Nov 15
|
Ken Fisher Portfolio: 12 Biggest Positions
|
|
Nov 15
|
13 Best Performing S&P 500 Stocks in the Last 5 Years
|
|
Nov 15
|
UPDATE 3-German watchdog considers Ozempic export ban amid Europe shortages
|
|
Nov 14
|
Investors increase holdings of weight-loss drug makers’ shares in Q3 -filings
|
|
Nov 8
|
Data on Pfizer’s New Weight Loss Pill Is Coming. Why it’s Crucial for the Stock.
|
|
Nov 8
|
Eli Lilly Slashed Its Earnings Guidance and Its Stock Went Up 5% Anyway. What's Next?
|
|
Nov 8
|
Same Drug, Two Prices: Why The Higher Price Prevails
|
|
Nov 7
|
3 Ultra-Safe Dividend Stocks to Buy Hand Over Fist in November
|
|
Nov 7
|
An obesity drug biotech gets buy-in from Eli Lilly, venture firms
|
|
Nov 7
|
Should You Believe in the High Growth Potential of Novo Nordisk A/S (NVO)?
|
|
Nov 6
|
Eli Lilly, Power Generators Lead Top S&P 500 Performers Monday
|
|
Nov 6
|
Polen Focus Growth Added Eli Lilly and Company (LLY) Due to its Durable Growth Potential
|
|
Nov 4
|
Eli Lilly and Company (NYSE:LLY) Q3 2023 Earnings Call Transcript
|
|
Nov 3
|
Eli Lilly Beats on Q3 Earnings: ETFs to Buy
|
|
Nov 3
|
Eli Lilly Just Added Another Potential Billion-Dollar Product: Is It a Buy?
|
|
Nov 3
|
Novo Nordisk isn’t alone: Sales of Ozempic rival Mounjaro explode as drugmaker Eli Lilly profits from Americans’ weight-loss craze
|
|
Nov 3
|
Company News for Nov 03, 2023
|